Company intelligence / Profile preview

Laboratorios Farmacéuticos ROVI

Madrid, Madrid, Spainrovi.es ↗

Ownership: Private
Employees: ~1037
Development stage: Commercial

Overview

Rovi is a specialized pharmaceutical company with a diverse portfolio of proprietary and licensed products. They have successfully developed and commercialized products including Bemiparin (a low-molecular-weight heparin) and an enoxaparin biosimilar, which has received marketing authorization in 26 European countries.

Therapeutic areas: PulmonologyCardiovascularMen's HealthRheumatologyEndocrinologyWomen's HealthOncologyNeurology
Modalities: Small moleculesbiologicalsbiosimilarslow-molecular-weight heparins
Industry: Biotech

Drug pipeline

5 assets

bemiparin

4 more assets in the full pipeline.

Partnerships

Moderna (COVID-19 vaccine manufacturing)Merck Sharp & Dohme (MSD)Laboratoires ServierNovartisAstellasOrexigen

Beyond the preview

Go deeper on Laboratorios Farmacéuticos ROVI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratorios Farmacéuticos ROVI.